MARKET

BIO-B

BIO-B

Bio Rad Laborato
NYSE
338.55
0.00
0.00%
Closed 16:00 04/12 EDT
OPEN
338.55
PREV CLOSE
338.55
HIGH
338.55
LOW
338.55
VOLUME
242
TURNOVER
0
52 WEEK HIGH
467.95
52 WEEK LOW
271.00
MARKET CAP
9.65B
P/E (TTM)
-15.5160
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BIO B last week (0408-0412)?
Weekly Report · 1d ago
BUZZ-OncoCyte jumps on partnership with Bio-Rad
OncoCyte shares rise 93.3% to $5.73 in extended trading. Company announces partnership with Bio-Rad for blood-based organ transplantation monitoring test GraftAssure. Shares of diagnostics company up 18.6% year-to-date.
Reuters · 5d ago
ONCOCYTE CORP - BIO-RAD EXPECTS TO MAKE EQUITY INVESTMENT IN SUPPORT OF DEAL
Reuters · 5d ago
ONCOCYTE CORP - BIO-RAD AND ONCOCYTE WILL CO-MARKET ASSAY INSIDE US AND GERMANY, WITH ONCOCYTE ACTING AS COMMERCIAL LEAD
Reuters · 5d ago
Bio Rad Laborato: Current report
Press release · 6d ago
BIO-RAD’S CHIEF OPERATING OFFICER ANDREW LAST TO RETIRE
Reuters · 6d ago
Weekly Report: what happened at BIO B last week (0401-0405)?
Weekly Report · 04/08 09:05
BIO RAD LABORATORIES INC <BIO.N>: RBC CUTS TARGET PRICE TO $474 FROM $480
Reuters · 04/08 06:23
More
About BIO-B
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO B real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO B stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO-B stock methods without spending real money on the virtual paper trading platform.